Order Article Reprints

Nomoto H, Kito K, Iesaka H, Oe Y, Kawata S, Tsuchida K, Yanagiya S, Miya A, Kameda H, Cho KY, et al. Favorable Effect of Pemafibrate on Insulin Resistance and β-Cell Function in Subjects with Type 2 Diabetes and Hypertriglyceridemia: A Subanalysis of the PARM-T2D Study. Pharmaceutics. 2023; 15(7):1838. https://doi.org/10.3390/pharmaceutics15071838

Nomoto, Hiroshi, Kenichi Kito, Hiroshi Iesaka, Yuki Oe, Shinichiro Kawata, Kazuhisa Tsuchida, Shingo Yanagiya, Aika Miya, Hiraku Kameda, Kyu Yong Cho, and et al. 2023. "Favorable Effect of Pemafibrate on Insulin Resistance and β-Cell Function in Subjects with Type 2 Diabetes and Hypertriglyceridemia: A Subanalysis of the PARM-T2D Study" Pharmaceutics 15, no. 7: 1838. https://doi.org/10.3390/pharmaceutics15071838

Nomoto, H., Kito, K., Iesaka, H., Oe, Y., Kawata, S., Tsuchida, K., Yanagiya, S., Miya, A., Kameda, H., Cho, K. Y., Sakuma, I., Manda, N., Nakamura, A., & Atsumi, T. (2023). Favorable Effect of Pemafibrate on Insulin Resistance and β-Cell Function in Subjects with Type 2 Diabetes and Hypertriglyceridemia: A Subanalysis of the PARM-T2D Study. Pharmaceutics, 15(7), 1838. https://doi.org/10.3390/pharmaceutics15071838